David Louis Kirschman, MD
Dr. Kirschman is founder and CEO of Aerobiotix; a former neurosurgeon with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space. He holds 55 issued US Patents for a wide range of medical devices. He received his BS in Biological Science from Colorado State University and medical doctor from University of Colorado School.
Steven MacDonald, MD
Dr. Steven MacDonald is a Professor of Orthopaedic Surgery at Western University, Chief of Orthopaedic and Chief of Surgery, at London Health Sciences Centre, University Campus in London, Ontario. He is a native of London, Ontario and received his undergraduate Bachelor of Science Degree at Western. He then received his medical degree from the University of Toronto and returned to Western for his orthopaedic training. Further training as an adult reconstructive fellow was obtained in Chicago, Illinois and in Bern, Switzerland. Dr. MacDonald has won many awards including, twice the John Charnley award from the Hip Society, the Frank Stinchfield award from the Hip Society, the Insall Award from the Knee Society and the Founders Medal from the Canadian Orthopaedic Research Society. He is a member of multiple orthopaedic organizations including the North American Hip Society, the International Hip Society and the North American Knee Society. Dr. MacDonald has been awarded 25 research grants for hip and knee replacement projects. He has published over 120 papers in research journals in the field of hip and knee surgery. He has lectured at over 200 national and international meetings. His current focus of research includes multiple randomized clinical trials on hip and knee replacements including the evaluation of new technology.
Keya Sadeghipour, PhD
Dr. Sadeghipour is a dean of College of Engineering at Temple University, Philadelphia, PA, since 2003. While a search for a permanent dean was conducted, he also served the College of Science and Technology as its interim dean from 2005-2007. He is professor of Mechanical Engineering and Bioengineering. His current research interests are in the areas of dental materials (NIH), Bioengineering (various sources), and Intelligent Manufacturing Systems. He has guided several research and industrial related projects and been involved in receiving over $8M funding from various industry and government sources. He has also been the principal author of numerous papers in national and international journals and publications. At Temple University, he received the Exceptional Research Award. National and international organizations to which he belongs include the American Society of Mechanical Engineers (ASME), the International Association for Dental Research (IADR), and the Society of Manufacturing Engineering (SME). He is a Program Evaluator for Accreditation Board for Engineering and Technology, Inc. (ABET)
Hadi Saleh, MD
Dr. Hadi Saleh was appointed CEO of the CeramTec Group on March 8, 2018. Since 2015, he has been Chief Operating Officer of CeramTec’s Executive Board, responsible for the Medical Applications Segment. He worked in the medical technology sector, where as Senior Vice President of Biomet Inc. and President of Biomet International he was previously responsible for all Biomet product lines worldwide outside of the US and Europe. In addition, he played a leading role in the Zimmer Holdings acquisition of Biomet Inc. Since 2001, Dr. Saleh has held a number of positions at Biomet, first at Biomet Germany, then Biomet Europe and finally at the parent company, Biomet Inc. in Warsaw, IN in the United States. Prior to this he studied and earned his doctorate at the universities in Frankfurt am Main and Mainz, worked as an orthopedist at St. Josef’s Hospital in Wiesbaden and at the University Clinic in Heidelberg and was a Senior Consultant at GAIA in Hamburg.
Peter F. Sharkey, MD
Dr. Sharkey is an internationally recognized expert and leader in the field of hip and knee replacement. He is a Professor of Orthopaedic Surgery at Thomas Jefferson University Hospital, Chairman for the Department of Orthopaedic Surgery at Riddle Hospital in Media, PA, and a member of the prestigious Hip and Knee Societies. Visiting orthopaedic surgeons and implant engineers routinely meet with and observe Dr. Sharkey’s innovations in surgical technique and patented implant and instrument designs. His research has led to hundreds of publications that have strongly influenced the practice of orthopaedic surgery.
Mr. Dimun has served as Chairman of Nascent Enterprises, LLC, a medical device venture investment & advisory firm since May 2001. Nascent provides strategic advisory services to numerous medical device businesses and portfolio companies. From March 1987 to May 2001, Mr. Dimun served as Executive Vice president & Chief Financial Officer of Vital Signs, Inc., a publicly held anesthesia, respiratory and sleep apnea medical device business building that medical device business from $3m in sales to $300m. The Company was ultimately sold to GE healthcare for $1 billion in 2008. During the last 20 years he has been an investor and mentor to several emerging growth medical enterprises that have matured to commercial status and became publicly traded companies. Mr. Dimun has been an investor in 32 medical device companies of which four became publicly traded entities and fourteen had successful exits.
Mr. Dimun has been a director of several public companies, including, Vital Signs, Inc., Bionx Implants, Inc., Colorado MedTech Inc., Photomedix, ISS Surgical Systems and numerous privately held companies in the healthcare industry. Nascent Enterprises provides numerous universities and foundations with entrepreneurial assistance to commercialize their medical technology. Additionally, Mr. Dimun serves as a limited partner and medical industry advisor to a Private Equity firm and an investment bank and currently is a Board member for the Parvizi Surgical Institute at Thomas Jefferson University Hospital.
Mr. Dimun previously held positions as a Certified Public Accountant with national accounting firms and served as Senior VP for an international merchant banking firm specializing in mergers & acquisitions. He served in the US Airforce in Asia as well as air force bases in the USA.